Recall Register

Food, drugs, devices › Abbott Gmbh & Co. KG

Device recall: Alinity ci -series System Control¿Module, Part Number 03R70 01 Product Usage: The Alinity ci series System Control Modul

FDA enforcement event 83235 · Class II · initiated 10 Jun 2019 · status Terminated · terminated 14 Jun 2023

DeviceVoluntary: Firm initiated1 product recordWiesbaden, N/A

Abbott Gmbh & Co. KG (Wiesbaden, N/A) initiated this device recall on 10 Jun 2019; FDA lists 1 product record under event 83235, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 968 device enforcement events initiated in 2019 carry the same class.

Status: Terminated, terminated 14 Jun 2023. Initiation: voluntary: firm initiated. Abbott Gmbh & Co. KG has 16 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Abbott Gmbh & Co. KG, Wiesbaden, N/A, Germany.

Reason for recall

"Abbott has identified an issue with all on market versions (v2.6.0 and v2.6.1) of Alinity ci series Software where incorrect results may occur after a system Stop due to the Alinity i re use of reaction vessels (RVs). This issue only occurs if the system is transitioned from Processing to Stopped to Idle."

Distribution

"Worldwide Distribution - US Nationwide"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2363-2019Alinity ci -series System Control¿Module, Part Number 03R70 01 Product Usage: The Alinity ci series System Control Module has a scalable design to provide full integration of clinical chemistry and immunoassay analysis. The Alinity ci series System Control Module includes a clinical chemistry module and an…1763 unitsClass IITerminated4 Sep 2019

Context

88%of 2019 device events are Class II968 events that year
1product record in this eventfirm median: 1
16events on this register for the firm

Other enforcement events for Abbott Gmbh & Co. KG

InitiatedProduct (first record)TypeClassRecords
19 Jun 2020Alinity ci series System Control Module (SCM); LN 3R70-01 Alinity ci series software versions, 3.1.1 and belowDeviceClass II1
12 May 2020Alinity C, Processing Module. Chemistry analyzer for in-vitro diagnostics.DeviceClass II1
24 Apr 2020ARCHITECT iGentamicin Reagent Kit - Product Usage: The measurements obtained are used in the diagnosis and treatment of DeviceClass II1
9 Mar 2020ARCHITECT HAVAB G Reagent Kit. List Number 6L27 25.DeviceClass II1
24 Jan 2020LN 3R70-01; software version 2.6.2 and earlier. The software is used with the Alinity i (LN 03R65-01) processing module DeviceClass II1
7 Nov 2019ARCHITECT HAVAB-G Calibrator, REF 6L27-01DeviceClass II1
23 Oct 2019Alinity c Carbon Dioxide Reagent Kit, Produced for Abbott by Sekisui Diagnostics P.E.I. Inc. Prince Edward Island CanadaDeviceClass II1
16 Sep 2019Alinity ci Level Sensor, Bulk SolutionDeviceClass II3
21 May 2019The Alinity ci-series System Control Modules which are configured with Alinity c Processing Modules. The Alinity ci-seriDeviceClass II1
15 Apr 2019Alinity c Cuvette Segments, List Number 04S47-01 Product Usage: The Alinity c Cuvettes are used on the Alinity c system DeviceClass II1

All 16 events for Abbott Gmbh & Co. KG

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Abbott has identified an issue with all on market versions (v2.6.0 and v2.6.1) of Alinity ci series Software where incorrect results may occur after a system Stop due to the Alinity i re use of reaction vessels (RVs). This issue only occurs if the system is transitioned from Processing to Stopped to Idle."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - US Nationwide"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 14 Jun 2023. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.